Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
暂无分享,去创建一个
Leonard Leibovici | Mical Paul | Galia Kariv | Vered Shani | Eyal Robenshtok | L. Leibovici | Eli Muchtar | M. Paul | E. Robenshtok | Eli Muchtar | V. Shani | G. Kariv
[1] Claude D Martin,et al. Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome* , 2003, Critical care medicine.
[2] Stephan Harbarth,et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. , 2003, The American journal of medicine.
[3] J. Miro,et al. Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. , 1988, Reviews of infectious diseases.
[4] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[5] Á. Pascual,et al. Bacteriemias por Acinetobacter baumannii: características clínicas y pronósticas , 2003 .
[6] L. Leibovici,et al. β lactam monotherapy versus β lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.
[7] F. Ballester,et al. Epidemiology of Sepsis in the Valencian Community (Spain), 1995–2004 , 2008, Infection Control & Hospital Epidemiology.
[8] G. Richards,et al. The epidemiology of sepsis. , 1973, Clinical orthopaedics and related research.
[9] F. J. Caballero,et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] F. Saulnier,et al. Multiple-drug–resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome* , 2006, Critical care medicine.
[11] G. Parmigiani,et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] Leibovici,et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection , 1998, Journal of internal medicine.
[13] G Sherman,et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.
[14] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[15] Patricia Muñoz,et al. Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] Steen Andreassen,et al. Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. , 2006, The Journal of antimicrobial chemotherapy.
[17] Jessina C. McGregor,et al. Controlling for Severity of Illness in Outcome Studies Involving Infectious Diseases: Impact of Measurement at Different Time Points , 2008, Infection Control & Hospital Epidemiology.
[18] M. Meisner,et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia , 2006, Critical care.
[19] C S Bryan,et al. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. , 1983, Reviews of infectious diseases.
[20] Julian P. T. Higgins,et al. Meta-Regression in Stata , 2008 .
[21] J. Gómez,et al. Clinical significance of pneumococcal bacteraemias in a general hospital: a prospective study 1989-1993. , 1995, The Journal of antimicrobial chemotherapy.
[22] Y. Carmeli,et al. Treatment with Fluoroquinolones or with β-Lactam-β-Lactamase Inhibitor Combinations Is a Risk Factor for Isolation of Extended-Spectrum-β-Lactamase-Producing Klebsiella Species in Hospitalized Patients , 2010, Antimicrobial Agents and Chemotherapy.
[23] J. A. H. Martínez,et al. Bacteriemias por P. aeruginosa: anlisis de los factores pronstico. Estudio prospectivo 1992-1998 , 2004 .
[24] P. Montravers,et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] Claude D Martin,et al. Ventilator-associated pneumonia: Breaking the vicious circle of antibiotic overuse* , 2007, Critical care medicine.
[26] Steen Andreassen,et al. The TREAT project: decision support and prediction using causal probabilistic networks. , 2007, International journal of antimicrobial agents.
[27] R. Zaragoza,et al. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[28] Jessina C. McGregor,et al. Impact of Empiric Antimicrobial Therapy on Outcomes in Patients with Escherichia coli and Klebsiella pneumoniae Bacteremia: A Cohort Study , 2008, BMC infectious diseases.
[29] M. Kollef,et al. Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. , 2004, Chest.
[30] Yee-Chun Chen,et al. Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center. , 2005, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[31] Fabio Salamanca-Gómez,et al. Roberto Martínez Martínez , 2011 .
[32] J. Rodríguez-Baño,et al. [Acinetobacter baumannii bacteremia: clinical and prognostic features]. , 2003, Enfermedades infecciosas y microbiologia clinica.
[33] S. Andreassen,et al. Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. , 2006, The American journal of medicine.
[34] D. Cook,et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. , 1999, American journal of respiratory and critical care medicine.
[35] A. Connor,et al. The way I see it: House officers need formal career development , 2002 .
[36] Á. Soriano,et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] K. Kaye,et al. Risk factors for ineffective therapy in patients with bloodstream infection. , 2005, Archives of internal medicine.
[38] A. Cayuela,et al. Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis , 2006, Critical care.
[39] Yehuda Carmeli,et al. Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality , 2007, Antimicrobial Agents and Chemotherapy.
[40] D. Snydman,et al. Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study , 2001, Annals of Internal Medicine.
[41] F. Gudiol,et al. Epidemiology and Prognosis of Bacteremia: A 10-y Study in a Community Hospital , 2002, Scandinavian journal of infectious diseases.
[42] Michael Y. Lin,et al. Delay of Active Antimicrobial Therapy and Mortality among Patients with Bacteremia: Impact of Severe Neutropenia , 2008, Antimicrobial Agents and Chemotherapy.
[43] D Greenwood,et al. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. , 1987, The Quarterly journal of medicine.
[44] I. Stiell,et al. Do β-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis , 2008 .
[45] L. Leibovici,et al. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. , 2003, BMJ.
[46] D. Mannino,et al. The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.
[47] J. Sunderram,et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003* , 2007, Critical care medicine.
[48] L. Leibovici,et al. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. , 2004, BMJ.
[49] Corinne Alberti,et al. Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity , 2004, Intensive Care Medicine.
[50] Marin H Kollef,et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. , 2002, Chest.
[51] R. Venkataraman. Can we prevent acute kidney injury? , 2008, Critical care medicine.
[52] P. Petrick,et al. Outcome of bacteraemia in patients admitted to the adult medical wards of the UKM hospital. , 2007, The Medical journal of Malaysia.
[53] A. Moreno,et al. Bacteremia and septic shock after solid-organ transplantation. , 2005, Transplantation proceedings.
[54] Á. Soriano,et al. Epidemiology and outcome of primary community-acquired bacteremia in adult patients , 2007, European Journal of Clinical Microbiology & Infectious Diseases.
[55] W. Johanson,et al. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. , 1986, The American review of respiratory disease.
[56] C. Hung,et al. Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome. , 2006, The Journal of antimicrobial chemotherapy.
[57] H T Sørensen,et al. Antibiotic therapy and outcome of monomicrobial gram-negative bacteraemia: a 3-year population-based study. , 1997, Scandinavian journal of infectious diseases.
[58] J. Rello,et al. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] J. Ruiz,et al. Six-Year Prospective Study of Risk and Prognostic Factors in Patients with Nosocomial Sepsis Caused by Acinetobacter baumannii , 1999, European Journal of Clinical Microbiology and Infectious Diseases.
[60] Á. Soriano,et al. Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa. , 2003, QJM : monthly journal of the Association of Physicians.
[61] J. M. Porcel,et al. Risk factors and outcome of community‐acquired pneumonia due to Gram‐negative bacilli , 2009, Respirology (Carlton South. Print).
[62] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[63] A. El‐Solh,et al. Etiology of severe pneumonia in the very elderly. , 2001, American journal of respiratory and critical care medicine.
[64] D. Macfarlane,et al. Flavobacterium odoratum ventriculitis treated with intraventricular cefotaxime. , 1985, The Journal of infection.
[65] J. Burke. Antibiotic resistance--squeezing the balloon? , 1998, JAMA.
[66] J. Rello,et al. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia , 2008, Critical care medicine.
[67] ICU-Acquired Pneumonia Study Group,et al. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit , 1996, Intensive Care Medicine.
[68] R. Auckenthaler,et al. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. , 1996, American journal of respiratory and critical care medicine.
[69] J. Rello,et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. , 2003, Chest.
[70] J. Ruiz,et al. Clinical significance of anaerobic bacteremias in a general hospital , 1993, The clinical investigator.
[71] Jessina C. McGregor,et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[72] A. Candiani,et al. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. , 2008, American journal of infection control.
[73] M. Struelens,et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[74] L. Johnson,et al. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[75] J. Miro,et al. Analysis of prognostic factors in 274 consecutive episodes of Pseudomonas aeruginosa bacteremia. , 1991, Antibiotics and chemotherapy.
[76] P. Devos,et al. Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. , 2003 .
[77] S. Chevret,et al. A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome. , 2000, The Journal of hospital infection.
[78] G. Hasçelik,et al. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli , 2005 .
[79] Joshua A. Doherty,et al. Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes. , 2008, The Journal of antimicrobial chemotherapy.
[80] S. Jamulitrat,et al. Factors affecting mortality outcome and risk of developing nosocomial bloodstream infection. , 1994, Infection control and hospital epidemiology.
[81] Jessina C. McGregor,et al. Impact of Empiric Antibiotic Therapy on Outcomes in Patients with Pseudomonas aeruginosa Bacteremia , 2006, Antimicrobial Agents and Chemotherapy.
[82] Leonard Leibovici,et al. β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.
[83] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[84] J. Rello,et al. Nosocomial bacteremia in a medical-surgical intensive care unit: Epidemiologic characteristics and factors influencing mortality in 111 episodes , 1994, Intensive Care Medicine.
[85] Jessina C. McGregor,et al. Empiric Antibiotic Therapy for Staphylococcus aureus Bacteremia May Not Reduce In-Hospital Mortality: A Retrospective Cohort Study , 2010, PloS one.
[86] S. Yusuf,et al. Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction: A Meta-Analysis of the Randomized Trials , 2005, Circulation.
[87] J. Miro,et al. Analysis of Prognostic Factors in 274 Consecutive Episodes of Pseudomonas aeruginosa Bacteremia1 , 1991 .
[88] P. Willcox,et al. Community-acquired bacteraemia; a prospective survey of 239 cases. , 1988, The Quarterly journal of medicine.
[89] J. Garnacho-Montero,et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis* , 2003, Critical care medicine.
[90] H. Dupont,et al. Outcome of postoperative pneumonia in the Eole study , 2003, Intensive Care Medicine.
[91] M. Niederman,et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia , 2006, European Respiratory Journal.
[92] H. Brodt,et al. Influence of antimicrobial treatment on mortality in septicemia. , 1999, Journal of chemotherapy.
[93] Jiaquan Xu,et al. Deaths: final data for 2006. , 2009, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[94] L. Goldani,et al. Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-β-lactamase-mediated multidrug resistance: a prospective observational study , 2006, Critical care.
[95] J. Decruyenaere,et al. Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures , 2006, Intensive Care Medicine.
[96] J. Gatell,et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. , 1996, Archives of internal medicine.
[97] L. Leibovici,et al. Propensity-matched analysis of appropriate empirical antibiotic treatment. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[98] N. Kim,et al. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[99] A. Cayuela,et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings , 2005, Intensive Care Medicine.
[100] M. Kollef,et al. Predictors of Hospital Mortality for Patients with Severe Sepsis Treated with Drotrecogin alfa (activated) , 2005, Pharmacotherapy.
[101] I. Stiell,et al. Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis. , 2008, CJEM.
[102] R. Bellomo,et al. The Spectrum of Practice in the Diagnosis and Management of Pneumonia in Patients Requiring Mechanical Ventilation. Australian and New Zealand Practice in Intensive Care (ANZPIC II) , 2005, Anaesthesia and intensive care.
[103] S. Nseir,et al. Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[104] Á. Soriano,et al. Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia. , 2008, The Journal of antimicrobial chemotherapy.
[105] D. Pittet,et al. Does antibiotic selection impact patient outcome? , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[106] Kara E. Flavin,et al. Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. , 2003, Chest.
[107] J. Lowes,et al. The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis. , 1996, QJM : monthly journal of the Association of Physicians.